Here are four quick points:
1. Technological advancements and synthetic bone grafts will spur the market’s growth.
2. North America is expected to grow at a compound annual growth rate of 3.5 percent to 2023.
3. An increasing emphasis on patient safety will continue to drive the market’s growth in North America.
4. The allografts sector is expected to reach $1.15 billion by 2023, due to the transition from autografts to allografts.
More articles on devices:
Amedica, SI-BONE, Stryker & more: 14 key notes
Stryker completes CareFusion’s VCF acquisition: 5 takeaways
FDA panel finds Cartiva SCI safe, effective: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
